However, there are other factors to consider, like side effects, cost, whether youre comfortable self-injecting, and availability
When you start treatment, your GI tract must adjust to slower stomach emptying and reduced appetite signals
While there are different types of fats, and some are better for us than others, it is not about cutting out all fat from our diets
In the fall of 2025, several new indications are expected for GLP-1s such as: Injectable semaglutide (NN9931) for metabolic dysfunction-associated steatohepatitis (MASH) Injectable semaglutide (Wegovy) and tirzepatide (Zepbound) for heart failure with preserved ejection fraction (HFpEF) in patients with obesity Oral semaglutide (Rybelsus) for major adverse cardiovascular events (MACE) risk reduction in adults with type 2 diabetes (T2DM) and established CVD and/or CKD Moreover, we are closely monitoring the pipeline for oral GLP-1s
At Buffalo Weight Loss , our expert physicians, Dr